337 related articles for article (PubMed ID: 9736745)
1. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria.
Calandra T; Spiegel LA; Metz CN; Bucala R
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11383-8. PubMed ID: 9736745
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor regulates innate γδ T-cell responses
Kim HK; Garcia AB; Siu E; Tilstam P; Das R; Roberts S; Leng L; Bucala R
FASEB J; 2019 Jun; 33(6):6919-6932. PubMed ID: 30817226
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria.
Roger T; Glauser MP; Calandra T
J Endotoxin Res; 2001; 7(6):456-60. PubMed ID: 11753217
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor and host innate immune responses to microbes.
Calandra T
Scand J Infect Dis; 2003; 35(9):573-6. PubMed ID: 14620137
[TBL] [Abstract][Full Text] [Related]
5. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
6. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.
Bacher M; Metz CN; Calandra T; Mayer K; Chesney J; Lohoff M; Gemsa D; Donnelly T; Bucala R
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7849-54. PubMed ID: 8755565
[TBL] [Abstract][Full Text] [Related]
7. Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.
Uchiyama T; Kamagata Y; Yan XJ; Kawachi A; Fujikawa H; Igarashi H; Okubo M
Clin Exp Immunol; 1989 Feb; 75(2):239-44. PubMed ID: 2784735
[TBL] [Abstract][Full Text] [Related]
8. Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.
Lee PK; Deringer JR; Kreiswirth BN; Novick RP; Schlievert PM
Infect Immun; 1991 Mar; 59(3):879-84. PubMed ID: 1997438
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.
Hofer MF; Newell K; Duke RC; Schlievert PM; Freed JH; Leung DY
Proc Natl Acad Sci U S A; 1996 May; 93(11):5425-30. PubMed ID: 8643591
[TBL] [Abstract][Full Text] [Related]
10. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Wakai M; Yoshioka M; Fujikawa H; Igarashi H
Microbiol Immunol; 1986; 30(5):469-83. PubMed ID: 3489157
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
Bohach GA; Fast DJ; Nelson RD; Schlievert PM
Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
[TBL] [Abstract][Full Text] [Related]
12. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis.
Hackett SP; Stevens DL
J Infect Dis; 1993 Jul; 168(1):232-5. PubMed ID: 8515117
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system.
Calandra T; Bucala R
Crit Rev Immunol; 1997; 17(1):77-88. PubMed ID: 9034724
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Migration Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the Immune System.
Calandra T; Bucala R
Crit Rev Immunol; 2017; 37(2-6):359-370. PubMed ID: 29773026
[TBL] [Abstract][Full Text] [Related]
16. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Yan XJ; Kohno M; Yoshioka M; Fujikawa H; Igarashi H; Okubo M; Awano F; Saito-Taki T
Clin Exp Immunol; 1987 Jun; 68(3):638-47. PubMed ID: 3498581
[TBL] [Abstract][Full Text] [Related]
17. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
Micusan VV; Mercier G; Bhatti AR; Reiser RF; Bergdoll MS; Oth D
Immunology; 1986 Jun; 58(2):203-8. PubMed ID: 3486824
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock.
Calandra T; Bucala R
J Inflamm; 1995-1996; 47(1-2):39-51. PubMed ID: 8913928
[TBL] [Abstract][Full Text] [Related]
19. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
20. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
